Resultados do 1º trimestre de 2025 da Syngenta: Desempenho robusto nas vendas de proteção de cultivos entre os principais destaques
Grupo Syngenta has announced financial results for the first quarter of 2025. Sales for the first quarter of 2025 were $7.3 billion, down $0.1 billion or -1%. At constant exchange rates (CER) sales increased by 3%. First quarter 2025 EBITDA increased strongly by 18% to $1.4 billion (26% CER).
Sales in the first quarter of 2025 were marginally lower in USD, despite a recovery in Crop Protection, with an end to channel destocking increasing demand, particularly in the US, and further strong growth in China. Sales were somewhat lower in other business segments; at ADAMA and Syngenta Group China the lower sales reflected the continued drive to focus on higher margin business and reduce sales of lower margin products.
Q1 2025 EBITDA significantly exceeded the previous year Q1 EBITDA, primarily driven by Crop Protection. Both Syngenta Group China and Seeds demonstrated solid performance. The EBITDA margin improved to 19.9%, an increase of 3.2 percentage points compared to prior year.
Crop Protection sales improved by 5% to $3.4 billion (+11% CER), compared to the same period last year, driven by the end of the channel destocking, particularly in the US. There was continued strong demand for new crop protection technologies such as ADEPIDYN technology, PLINAZOLIN technology and TYMIRIUM technology, supported by a general stabilization of the market. In North America and China, where new products continued to fuel growth, sales were up by 20% and 12% respectively. Across all geographies, sales of Biologicals continued their strong growth.
ADAMA sales decreased by 5% to $1 billion (-3% CER) due to a continued strong focus on driving higher margin business and exiting low margin products. For several quarters, ADAMA has been strategically steering its sales towards a more differentiated portfolio of formulations in higher value-added markets.
Syngenta Seeds recorded sales of $1.4 billion, a decrease of 2% in USD (+1% CER) compared to the same period last year. Seeds generated strong growth in China, with sales increasing by 18%, and a 4% rise in the Vegetables and Flowers business, together offsetting lower Field Crop sales in the US.
Syngenta Group China sales declined by 6% (-5% CER) to $2.5 billion versus the same period last year, largely due to the continued strategic reduction of low-margin businesses. The Seeds and Crop Protection businesses achieved strong growth.
Syngenta Group EBITDA margin improved strongly in the first quarter of 2025 as all businesses continued to successfully implement operational efficiency and productivity measures. Syngenta Group also benefited from lower raw material costs and the US recovery also had a positive impact on profitability with its higher margin business mix.
Cash flow in Q1 2025 continued to improve versus prior year, confirming the positive development in 2024, driven by improvement in margin and working capital.
While anticipating further stabilization in the Crop Protection and Seeds markets, the Group will maintain a balanced focus on investments in R&D and innovation, cost discipline, productivity, and cash flow conversion to drive long-term profitable growth.
See the full report aqui.
Receba a Newsletter hoje mesmo!
